07:33 July 18, 2025
| No. | Stock Name | Price(USD) | Bullish | Fair Value(USD) | Financial Health Status | Profitability Rating | Analyst Rating | P/E Ratio | Market Capitalization(USD) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Nike | 72.98 | 65 | 77.00 | Moderate–strong with solid cash reserves | Moderate to Strong | Moderate Buy | 34.8 | 96 Billion |
| 2 | Procter & Gamble | 155.62 | 145 | 178 | Strong | Moderate to Strong | Moderate Buy | 24.7 | 365 Billion USD |
| 3 | Intel | 22 | 26 | 40 | Healthy with Strategic CapEx | Recovering | Hold / Buy | 14.7 | 140 Billion |
| 4 | Pfizer | 24.5 | 30 | 35 | Strong Balance Sheet, Ample Cash | Stable | Buy | 12.4 | 157 Billion |
| 5 | PayPal Holdings | 73.8 | 80 | 85 | Resilient Financials, Investment Capacity | Moderate | Hold to Moderate Buy | 14.7 | 146 Billion |
| 6 | Lumen Technologies Inc. | 1.3 | 5 | 10 | Stable to Strong | Moderate to Strong | Moderate Buy | 10.8 | 167 Billion |
| 7 | 3M | 159 | 190 | 125 | Solid Operating Cash Flow, Ongoing Restructuring | Moderate, Recovering | Hold to Moderate Buy | 10.6 | 55 Billion |
| 8 | Cisco Systems, Inc. | 46.2 | 50 | 65 | Very Strong | Strong | Moderate Buy | 13.2 | 187 Billion |
| 9 | CVS Health Corporation | 60 | 62 | 70 | Stable | Moderate to Strong | Moderate Buy | 8.6 | 74 Billion |
| 10 | Bristol-Myers Squibb | 43.8 | 48 | 56 | Moderate to Strong | Moderate | Moderate Buy | 11.6 | 91 Billion |
